These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 16973349

  • 1. Anti-angiogenic, vascular-disrupting and anti-metastatic activities of vinflunine, the latest vinca alkaloid in clinical development.
    Kruczynski A, Poli M, Dossi R, Chazottes E, Berrichon G, Ricome C, Giavazzi R, Hill BT, Taraboletti G.
    Eur J Cancer; 2006 Nov; 42(16):2821-32. PubMed ID: 16973349
    [Abstract] [Full Text] [Related]

  • 2. Vinflunine potentiates the activity of cisplatin but not 5-fluorouracil in a transplantable murine adenocarcinoma model.
    Shnyder SD, Cooper PA, Gyselinck N, Hill BT, Double JA, Bibby MC.
    Anticancer Res; 2003 Nov; 23(6C):4815-20. PubMed ID: 14981930
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Vinflunine, the latest Vinca alkaloid in clinical development. A review of its preclinical anticancer properties.
    Kruczynski A, Hill BT.
    Crit Rev Oncol Hematol; 2001 Nov; 40(2):159-73. PubMed ID: 11682323
    [Abstract] [Full Text] [Related]

  • 5. Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells.
    Jean-Decoster C, Brichese L, Barret JM, Tollon Y, Kruczynski A, Hill BT, Wright M.
    Anticancer Drugs; 1999 Jul; 10(6):537-43. PubMed ID: 10885901
    [Abstract] [Full Text] [Related]

  • 6. Vinflunine: review of a new vinca alkaloid and its potential role in oncology.
    Ng JS.
    J Oncol Pharm Pract; 2011 Sep; 17(3):209-24. PubMed ID: 20584744
    [Abstract] [Full Text] [Related]

  • 7. Microtubule-targeting agents in angiogenesis: where do we stand?
    Pasquier E, Honoré S, Braguer D.
    Drug Resist Updat; 2006 Sep; 9(1-2):74-86. PubMed ID: 16714139
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Vinflunine: drug safety evaluation of this novel synthetic vinca alkaloid.
    Schutz FA, Bellmunt J, Rosenberg JE, Choueiri TK.
    Expert Opin Drug Saf; 2011 Jul; 10(4):645-53. PubMed ID: 21524237
    [Abstract] [Full Text] [Related]

  • 10. Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubules.
    Ngan VK, Bellman K, Panda D, Hill BT, Jordan MA, Wilson L.
    Cancer Res; 2000 Sep 15; 60(18):5045-51. PubMed ID: 11016627
    [Abstract] [Full Text] [Related]

  • 11. Vinflunine as second-line treatment in platin-resistant metastatic urothelial carcinoma: a review.
    Gerullis H, Ecke T, Eimer C, Wishahi M, Otto T.
    Anticancer Drugs; 2011 Jan 15; 22(1):9-17. PubMed ID: 20948429
    [Abstract] [Full Text] [Related]

  • 12. A comparison of antiangiogenic therapies for the prevention of liver metastases.
    Mi J, Sarraf-Yazdi S, Zhang X, Cao Y, Dewhirst MW, Kontos CD, Li CY, Clary BM.
    J Surg Res; 2006 Mar 15; 131(1):97-104. PubMed ID: 16242720
    [Abstract] [Full Text] [Related]

  • 13. Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activities.
    Yanase K, Yoshiji H, Ikenaka Y, Noguchi R, Kitade M, Kaji K, Yoshii J, Namisaki T, Yamazaki M, Asada K, Tsujimoto T, Akahane T, Uemura M, Fukui H.
    Oncol Rep; 2007 Feb 15; 17(2):441-6. PubMed ID: 17203185
    [Abstract] [Full Text] [Related]

  • 14. Ligustrazine inhibits B16F10 melanoma metastasis and suppresses angiogenesis induced by Vascular Endothelial Growth Factor.
    Chen L, Lu Y, Wu JM, Xu B, Zhang LJ, Gao M, Zheng SZ, Wang AY, Zhang CB, Zhang WW, Lei N.
    Biochem Biophys Res Commun; 2009 Aug 21; 386(2):374-9. PubMed ID: 19523924
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vinflunine, a novel microtubule inhibitor, suppresses calmodulin interaction with the microtubule-associated protein STOP.
    Makarov AA, Tsvetkov PO, Villard C, Esquieu D, Pourroy B, Fahy J, Braguer D, Peyrot V, Lafitte D.
    Biochemistry; 2007 Dec 25; 46(51):14899-906. PubMed ID: 18052208
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice.
    Bequet-Romero M, Ayala M, Acevedo BE, Rodríguez EG, Ocejo OL, Torrens I, Gavilondo JV.
    Angiogenesis; 2007 Dec 25; 10(1):23-34. PubMed ID: 17273909
    [Abstract] [Full Text] [Related]

  • 20. Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid.
    Kruczynski A, Colpaert F, Tarayre JP, Mouillard P, Fahy J, Hill BT.
    Cancer Chemother Pharmacol; 1998 Dec 25; 41(6):437-47. PubMed ID: 9554586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.